Publisher
Springer Berlin Heidelberg
Reference10 articles.
1. AIDS Group of the United Kingdom Haemophilia Center Directors: Prevalence of antibo- dy to HTLV-III in hemophiliacs in the United Kingdom. Br Med J 1986; 293: 175–176
2. Allain JP (1986) Prevalence of HTLV-III/LAV antibodies in patients with hemophilia and in their sexual partners in France. New Engl J Med; 315: 517–518
3. Feng Y, Broder CC, Kennedy PE, Berger EA (1996) HIV-1 entry cofactors: Functional cDNA cloning of a seven transmembrane, G protein-coupled receptor. Science; 272: 872–877
4. Kaiser R, Kasper P, Kupfer B, et al (1997) Clonal HIV-infection of seven hemophilia B-patients: virus diversification and course of disease. Biotest Bull; 5: 269–270
5. Ragni MV, Tegtmeier GE, Levy JA, et al (1986) AIDS retrovirus antibodies in hemophiliacs treated with factor-VIII or factor-IX concentrates, cryoprecipitate or fresh frozen plasma: Prevalence, seroconversion rate, and clinical correlations. Blood; 67: 592–595